Hu Xiaohong, Han Mei, Liu Jing, Li Feng, Cui Yanchao
Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Appl Biochem Biotechnol. 2024 Nov;196(11):8026-8042. doi: 10.1007/s12010-024-04965-9. Epub 2024 Apr 26.
Cedrol is a major bioactive compound present in the Cedrus atlantica with numerous biological properties. In this study, we elucidated the neuroprotective properties of cedrol against ischemic infarction in animal and in vitro studies. A cerebral ischemic/reperfusion model was induced in adult Wistar rats, and oxygen-glucose deprivation/reperfusion was induced in SH-SY5Y neuronal cells and treated with different concentrations of cedrol. The percentage of water content, cerebral infarct, and neurological deficit score was assessed in experimental rats. The acetylcholinesterase activity and inflammatory cytokines were quantified to analyze the anti-inflammatory potency of cedrol. Oxidative stress marker malondialdehyde and antioxidants were quantified to evaluate the antioxidant potency of cedrol in an ischemic condition. The neuroprotective potency of cedrol was confirmed by histopathological analysis of the brain tissue of cedrol-treated I/R-induced rats. In in vitro studies, the MTT and LDH assays were performed in cedrol-treated OGD/R SH-SY5Y cells to analyze the cytoprotective effect of cedrol. The anti-inflammatory property of cedrol was confirmed by quantifying the pro-inflammatory cytokine levels in OGD/R-induced cedrol-treated SH-SY5Y cells. The results obtained prove that cedrol significantly prevents brain edema, neurological deficits, acetylcholinesterase activity, and oxidative damage in ischemic-induced rats. It inhibited neuroinflammation in ischemic-induced rats and also in in vitro models. The neuroprotective effect of cedrol during an ischemic condition was authentically established with histological analysis in an animal model and cell survival assays in an in vitro model. Overall, our results confirm that cedrol is a potent alternative drug to treat cerebral ischemia in the future.
雪松醇是大西洋雪松中存在的一种主要生物活性化合物,具有多种生物学特性。在本研究中,我们在动物和体外研究中阐明了雪松醇对缺血性梗死的神经保护特性。在成年Wistar大鼠中诱导建立脑缺血/再灌注模型,并在SH-SY5Y神经元细胞中诱导氧糖剥夺/再灌注,然后用不同浓度的雪松醇进行处理。评估实验大鼠的含水量百分比、脑梗死面积和神经功能缺损评分。对乙酰胆碱酯酶活性和炎性细胞因子进行定量分析,以分析雪松醇的抗炎能力。对氧化应激标志物丙二醛和抗氧化剂进行定量分析,以评估雪松醇在缺血条件下的抗氧化能力。通过对经雪松醇处理的缺血/再灌注诱导大鼠脑组织进行组织病理学分析,证实了雪松醇的神经保护能力。在体外研究中,对经雪松醇处理的氧糖剥夺/再灌注SH-SY5Y细胞进行MTT和LDH测定,以分析雪松醇的细胞保护作用。通过定量氧糖剥夺/再灌注诱导的经雪松醇处理的SH-SY5Y细胞中的促炎细胞因子水平,证实了雪松醇的抗炎特性。所得结果证明,雪松醇可显著预防缺血诱导大鼠的脑水肿、神经功能缺损、乙酰胆碱酯酶活性和氧化损伤。它在缺血诱导的大鼠以及体外模型中均抑制神经炎症。通过动物模型中的组织学分析和体外模型中的细胞存活测定,确凿地证实了雪松醇在缺血条件下的神经保护作用。总体而言,我们的结果证实雪松醇是未来治疗脑缺血的一种有效替代药物。